Cargando…
Design, Synthesis, and Biological Evaluation of 2-Anilino-4-Triazolpyrimidine Derivatives as CDK4/HDACs Inhibitors
PURPOSE: To enhance the cytotoxicities of our obtained CDK4 inhibitors and get CDK4/HDACs inhibitors with potent enzymatic inhibitory and anti-proliferative activities. METHODS: A series of novel CDK4/HDACs inhibitors were designed and synthesized by incorporating the HDAC pharmacophores (hydroxylam...
Autores principales: | Wang, Suhua, Han, Siyuan, Cheng, Weiyan, Miao, Ruoyang, Li, Shasha, Tian, Xin, Kan, Quancheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012344/ https://www.ncbi.nlm.nih.gov/pubmed/35431540 http://dx.doi.org/10.2147/DDDT.S351049 |
Ejemplares similares
-
Design, synthesis, and biological study of 4-[(2-nitroimidazole-1H-alkyloxyl)aniline]-quinazolines as EGFR inhibitors exerting cytotoxicities both under normoxia and hypoxia
por: Cheng, Weiyan, et al.
Publicado: (2019) -
Discovery of Anilino-1,4-naphthoquinones as Potent
EGFR Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation,
and Comprehensive Molecular Modeling
por: Mahalapbutr, Panupong, et al.
Publicado: (2022) -
Aberrant CDK9 expression within chordoma tissues and the therapeutic potential of a selective CDK9 inhibitor LDC000067
por: Shen, Shen, et al.
Publicado: (2020) -
2-(4-Chloroanilino)pyridine
por: Fairuz, M. Zainal Abidin, et al.
Publicado: (2008) -
2-(4-Chloroanilino)quinoxaline
por: Idris, Azila, et al.
Publicado: (2008)